← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2013Last known activity
Oct 1, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (2)
- NCT03638830Overall official - principal investigatorPhase 2Oct 1, 2018
- NCT01889433Overall official - principal investigatorPhase 3Nov 1, 2013
Details
- Last known activity
- Oct 1, 2018